Diverticulitis FAQs

In the U.S., diverticular disease is a frequent outpatient gastrointestinal diagnosis. The prevalence of diverticulosis appears to be increasing over time, as well as rates of diverticulitis. Hospital admissions for diverticulitis are on the rise, especially in patients under the age of 40 years old.2 The chart below answers common questions about diverticulitis, including risk factors, medical management, when and which antibiotics to consider, etc.

Abbreviations: BID = twice daily; CRP = c-reactive protein; CT = computed tomography; IV = intravenous; NSAID = nonsteroidal anti-inflammatory drug; TID = three times daily; WBC = white blood cell.

Question

Answer/Pertinent Information

What is the difference between diverticulosis and diverticulitis?

DiverticulOSIS is when an abnormal sac or pouch forms in a weak section of the colon, usually in the sigmoid or descending colon.1,3 Diverticulosis is often asymptomatic, but found during a colonoscopy. It affects about 5% of people younger than 40 years old, but up to 50% of people older than 60 years old.3

DiverticulITIS is when the sac or pouch becomes inflamed or infected and is associated with symptoms
(e.g., abdominal pain, nausea, tenderness, low fever). Diverticulitis can be uncomplicated. It becomes complicated if the following are present: abscess, fistula, stricture, bowel obstruction, or peritonitis with perforation.3,7

What are risk factors for diverticulitis?

Though data are not robust, risk factors for diverticulitis may include:1-3,5

  • age (risk increases with age)
  • use of alcohol or tobacco
  • NSAIDs (Regular use [e.g., ≥2 times/week] is associated with about a 70% increased risk of diverticulitis.1)
  • physical inactivity, increased body mass index (BMI), and obesity

Long-term opioid or NSAID use may be associated with an increased risk of perforated diverticulitis. And NSAIDs may also increase risk of gastrointestinal (GI) bleeding.1,17

There also may be an association between an increased risk of diverticulosis and/or diverticulitis with diets low in fiber, high in refined carbohydrates, and high in red meat.3,5

The most common risk factors for RECURRENT diverticulitis are age younger than 50 years old AND a history of diverticulitis.2

What are symptoms of diverticulitis?

The most common symptom of diverticulitis is constant abdominal pain and tenderness, usually in the left-lower quadrant (may be in the right-lower quadrant in the Asian population). Pain often worsens with movement.1

Other symptoms can include abdominal distention, diarrhea, nausea, vomiting, and constipation.1

Constipation and abdominal distention may indicate an obstruction.1 Obstructions are more common AFTER the first episode of diverticulitis.1

How is diverticulitis diagnosed?

The most common diverticulitis presentation involves left-lower quadrant abdominal pain WITHOUT vomiting.2

Disease severity can be assessed with vital signs (e.g., temperature, heart rate, blood pressure), laboratory tests (e.g., CRP, WBC) and an abdominal exam. Hemodynamic instability (e.g., high fever, hypotension, tachycardia), abdominal rigidity and guarding, and significantly elevated CRP or WBCs are often associated with more severe disease, abscesses, perforation, and generalized peritonitis.1,2

Imaging (abdominal CT scan) is recommended for patients with severe signs and symptoms (e.g., severe pain, hemodynamic compromise, diffuse tenderness, abdominal guarding or rigidity, significantly elevated WBC or
CRP [>50 mg/L]).1,2

  • CT scans may be appropriate for patients with mild diverticulitis who do not respond to initial medical management.1
  • Can consider CT scans for immunocompromised patients with mild symptoms, as they may not mount an inflammatory response.1
  • Imaging is more useful when diagnosing diverticulitis for the first time in a patient. Imaging may not be necessary for subsequent episodes, especially if presentation and severity are similar to prior episodes.1,2

How is diverticulitis classified?

There are several available diverticulitis classification systems. The Modified Hinchey classification (based on CT findings) is commonly used in practice and in clinical trials to classify diverticulitis:1,2

  • Stage 0: clinically mild diverticulitis, or diverticula with colonic wall thickening
  • Stage Ia: colonic wall thickening with phlegmon (pericolic fat)
  • Stage Ib: diverticulitis with pericolic or mesenteric abscess
  • Stage II: diverticulitis with intra-abdominal abscess distant from inflammation, pelvic or retroperitoneal abscess
  • Stage III: diverticulitis with generalized purulent peritonitis
  • Stage IV: diverticulitis with generalized fecal peritonitis

How should patients with diverticulitis be medically managed?

Most patients with uncomplicated diverticulitis (Hinchey stage 0 or Ia) can be managed as outpatients. Some patients with Hinchey stage Ib disease (small peridiverticular abscess) can also be managed as outpatients (e.g., those WITHOUT severe symptoms, unstable comorbid conditions, or immunosuppression).1

Patients should be admitted if they have high fever (temperature >101.5°F [>38.6°C]), increased WBCs, complications (e.g., abscess, perforation), immunosuppression, serious coexisting conditions, a lack of home support, a need for pain control, or an inability to take things by mouth.3

There are little data for dietary management of acute diverticulitis. It is common for patients with diverticulitis to start with nothing by mouth (especially hospitalized patients with severe symptoms or with planned surgery) or a clear liquid diet and to gradually advance to a solid, low-fiber diet once symptoms begin to improve.1

Which medications should be used to treat diverticulitis?

Use acetaminophen and antispasmodics (e.g., dicyclomine) first-line to manage diverticulitis-associated pain.1

  • If possible, avoid NSAID and opioids. There are no data using these in acute diverticulitis.1 However, short-term opioids (e.g., morphine) are sometimes needed for severe pain uncontrolled with first-line options.1

Antibiotics may not be necessary for otherwise healthy patients with uncomplicated diverticulitis. Current thinking is that diverticulitis involves inflammation, genetics, diet, lifestyle, meds, and gastrointestinal microorganisms.1,17 Symptomatic management WITHOUT antibiotics leads to similar outcomes (e.g., complications, recovery time) compared to treatment with antibiotics in immunocompetent patients with uncomplicated diverticulitis, less severe pain and reliable follow-up [Evidence Level B-2].2,6,7 However, antibiotics can be considered in patients who do not improve with medical management and “watchful waiting” for two or three days.1

Antibiotics are considered first-line treatment for patients:1,7

  • with severe symptoms or complicated diverticulitis (e.g., abscess, peritonitis, bowel obstruction)
  • with multiple or significant comorbidities (e.g., chronic kidney disease)
  • who are immunocompromised
  • who are pregnant

Which antibiotics are appropriate for diverticulitis?

Promote antimicrobial stewardship and select antibiotics to cover gram-negative and anaerobic bacteria (e.g., Escherichia coli, Klebsiella species, Bacteroides fragilis).2

Use the oral route (instead of IV) for stable, uncomplicated, immunocompetent patients. No particular antibiotic regimen has been shown to work better than any other.5 Usually use about seven days of one of the following:3,4,8,9

  • Amoxicillin/clavulanic acid 875 mg orally BID or 500 mg TID
  • TMP/SMX DS orally BID plus metronidazole 500 mg orally TID
  • Fluoroquinolone (e.g., ciprofloxacin 500 mg orally BID) plus metronidazole 500 mg orally TID
    • Limit use of quinolones to patients unable to take or tolerate other antibiotic options due to principles of antibiotic stewardship and potential for adverse effects.

Save IV antibiotics for patients with perforations, large abscesses (i.e., >3 to 4 cm), unable to tolerate oral intake, or bowel obstruction.1 Convert to oral antibiotics once clinically improving (e.g., resolution of fever, WBC trending down). Usually recommend four to five days of antibiotics if the infection source is controlled (e.g., surgical containment by draining abscess) [Evidence Level A-1].11 For immunocompromised patients or if the source of the infection is difficult to control, longer durations of therapy may be needed based on clinical response.3,4,8-13 Consider antibiotics with low resistance (e.g., <10%) on antibiograms. Common IV regimens include:1,8,9,14

  • Ceftriaxone 1 gram IV every 12 hours plus metronidazole 500 mg IV every eight to 12 hours
  • Ciprofloxacin 400 mg IV every 12 hours plus metronidazole 500 mg IV every eight to 12 hours

How can recurrent episodes of diverticulitis be prevented?

Though data are limited, dietary and lifestyle changes may be tried to reduce the risk of recurrent diverticulitis, including:1

  • maintaining a healthy weight
  • getting regular exercise
  • avoiding regular or long-term use of NSAIDs, opioids, and corticosteroids
  • getting 25 to 30 grams of fiber in daily with high-fiber foods (e.g., bran, whole wheat, apples or pears [with the skin], beans, vegetables) or a fiber supplement14-16
  • limiting intake of red meat

There are not enough data to support the use of mesalamine, rifaximin, or probiotics to prevent recurrent diverticulitis.1

Dispel the myth that all patients with diverticulitis need to avoid nuts, seeds, and popcorn. There are not data to confirm that nuts, seeds, and popcorn lead to or increase diverticulitis flares.1,5

Use diverticulitis flares as an opportunity to review medication regimens for anything that might be problematic
(e.g., NSAID, opioids).1

 

Levels of Evidence

In accordance with our goal of providing Evidence-Based information, we are citing the LEVEL OF EVIDENCE for the clinical recommendations we publish.

Level

Definition

Study Quality

A

Good-quality patient-oriented evidence.*

  1. High-quality RCT
  2. SR/Meta-analysis of RCTs with consistent findings
  3. All-or-none study

B

Inconsistent or limited-quality patient-oriented evidence.*

  1. Lower-quality RCT
  2. SR/Meta-analysis with low-quality clinical trials or of studies with inconsistent findings
  3. Cohort study
  4. Case control study

C

Consensus; usual practice; expert opinion; disease-oriented evidence (e.g., physiologic or surrogate endpoints); case series for studies of diagnosis, treatment, prevention, or screening.

*Outcomes that matter to patients (e.g., morbidity, mortality, symptom improvement, quality of life).

RCT = randomized controlled trial; SR = systematic review [Adapted from Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004;69:548-56. http://www.aafp.org/afp/2004/0201/p548.pdf.]

Project Leader in preparation of this clinical resource (351211): Beth Bryant, Pharm.D. BCPS, Assistant Editor

References

  1. Swanson SM, Strate LL. Acute colonic diverticulitis. Ann Intern Med 2018;168:ITC65-80.
  2. Francis NK, Sylla P, Abou-Khalil M, et al. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc 2019;33:2726-41.
  3. Young-Fadok TM. Diverticulitis. N Engl J Med 2018;379:1635-42.
  4. Welling DR. Medical treatment of diverticular disease. Clin Colon Rectal Surg 2004;17:163-8.
  5. Sleisenger MH, Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. Philadelphia Saunders/Elsevier, 2010. Internet resource.
  6. Desai M, Fathallah J, Nutalapati V, Saligram S. Antibiotics versus no antibiotics for acute uncomplicated diverticulitis: a systematic review and meta-analysis. Dis Colon Rectum 2019;62:1005-12.
  7. Rezapour M, Stollman N. Antibiotics in uncomplicated acute diverticulitis: to give or not to give? Inflamm Intest Dis 2018;3:75-9.
  8. Wilkins T, Embry K, George R. Diagnosis and management of acute diverticulitis. Am Fam Physician 2013;87:612-20.
  9. National Institute for Health and Care Excellence. Guideline. Diverticular disease: diagnosis and management (draft for consultation, June 2019). https://www.nice.org.uk/guidance/GID-NG10064/documents/draft-guideline-2. (Accessed September 30, 2019).
  10. Mazuski JE, Tessier JM, May AK, et al. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 2017;18:1-76.
  11. Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;372:1996-2005. [Erratum N Engl J Med 2018;378:686].
  12. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-64 [Erratum Clin Infect Dis 2010;50:1695].
  13. Chow AW, Evans GA, Nathens AB, et al. Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol 2010;21:11-37.
  14. Clinical Pharmacology powered by ClinicalKey. Tampa (FL): Elsevier. 2019. http://www.clinicalkey.com. (Accessed October 7, 2019).
  15. NIH. Eating, diet, & nutrition for diverticular disease. What should I eat if I have diverticulosis or diverticulitis? https://www.niddk.nih.gov/health-information/digestive-diseases/diverticulosis-diverticulitis/eating-diet-nutrition. (Accessed October 15, 2019).
  16. University of California San Francisco Health. Diverticular disease and diet. https://www.ucsfhealth.org/education/diverticular_disease_and_diet/. (Accessed October 15, 2019).
  17. Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 2019;156:1282-98.

Cite this document as follows: Clinical Resource, Diverticulitis FAQs. Pharmacist’s Letter/Prescriber’s Letter. December 2019.

Related Articles